Skip to main content
. 2021 Oct 28;24(12):103362. doi: 10.1016/j.isci.2021.103362

Figure 3.

Figure 3

Competition TR-FRET ligand binding studies using F-propranolol as a tracer and unlabeled propranolol, ICI 118,551, and isoprenaline as competitors

(A) β2AR membranes, (B) DDM-β2AR, (C) DIBMALP-β2AR curves show normalized combined data of n = 3, error bars show ±SEM.